Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by Ilmarinen Mutual Pension Insurance Co

Ilmarinen Mutual Pension Insurance Co grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGNGet Rating) by 10.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,000 shares of the medical equipment provider’s stock after purchasing an additional 2,000 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Align Technology were worth $14,458,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Achmea Investment Management B.V. acquired a new position in shares of Align Technology during the 4th quarter valued at about $2,863,000. TD Asset Management Inc. boosted its position in shares of Align Technology by 12.7% during the 4th quarter. TD Asset Management Inc. now owns 119,311 shares of the medical equipment provider’s stock valued at $78,409,000 after acquiring an additional 13,482 shares during the last quarter. Brendel Financial Advisors LLC acquired a new position in shares of Align Technology during the 4th quarter valued at about $206,000. Financial Counselors Inc. boosted its position in shares of Align Technology by 5.0% during the 4th quarter. Financial Counselors Inc. now owns 8,959 shares of the medical equipment provider’s stock valued at $5,888,000 after acquiring an additional 426 shares during the last quarter. Finally, Ithaka Group LLC boosted its position in shares of Align Technology by 9.3% during the 4th quarter. Ithaka Group LLC now owns 36,994 shares of the medical equipment provider’s stock valued at $24,312,000 after acquiring an additional 3,154 shares during the last quarter. 88.17% of the stock is currently owned by institutional investors.

In other Align Technology news, CEO Joseph M. Hogan acquired 6,700 shares of the business’s stock in a transaction on Wednesday, May 4th. The stock was purchased at an average price of $298.48 per share, for a total transaction of $1,999,816.00. Following the completion of the transaction, the chief executive officer now owns 174,801 shares of the company’s stock, valued at approximately $52,174,602.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

ALGN has been the topic of several recent research reports. Stifel Nicolaus lowered their price target on shares of Align Technology from $575.00 to $425.00 in a research report on Thursday, April 28th. TheStreet cut shares of Align Technology from a “b-” rating to a “c+” rating in a research report on Monday, April 25th. Credit Suisse Group decreased their target price on shares of Align Technology from $722.00 to $418.00 in a research report on Wednesday, May 4th. Robert W. Baird decreased their target price on shares of Align Technology from $625.00 to $510.00 and set an “outperform” rating on the stock in a research report on Thursday, April 28th. Finally, Zacks Investment Research raised shares of Align Technology from a “sell” rating to a “hold” rating and set a $454.00 target price on the stock in a research report on Tuesday, March 22nd. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $578.27.

Shares of NASDAQ ALGN traded down $10.83 during mid-day trading on Tuesday, hitting $258.13. 2,246,628 shares of the company were exchanged, compared to its average volume of 975,418. The stock has a 50 day simple moving average of $397.22 and a 200-day simple moving average of $520.96. Align Technology, Inc. has a 1-year low of $254.48 and a 1-year high of $737.45. The firm has a market cap of $20.34 billion, a price-to-earnings ratio of 29.04, a price-to-earnings-growth ratio of 4.48 and a beta of 1.76.

Align Technology (NASDAQ:ALGNGet Rating) last issued its quarterly earnings results on Wednesday, April 27th. The medical equipment provider reported $1.70 earnings per share for the quarter, missing the consensus estimate of $1.99 by ($0.29). Align Technology had a return on equity of 19.90% and a net margin of 17.51%. The company had revenue of $973.22 million for the quarter, compared to analyst estimates of $1 billion. During the same period in the prior year, the business earned $2.51 earnings per share. On average, equities analysts anticipate that Align Technology, Inc. will post 8.65 EPS for the current year.

Align Technology Company Profile (Get Rating)

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Featured Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGNGet Rating).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.